February 8, 2022 01:22 PM ESTUpdated February 11, 10:32 AM
Coronavirus
Manufacturing

Covid-19 jab pro­duc­tion has stopped at J&J's vac­cine birth­place

Josh Sullivan

A J&J man­u­fac­tur­ing site in Lei­den, Nether­lands has halt­ed its pro­duc­tion of Covid-19 vac­cines, in fa­vor of mak­ing an­oth­er vac­cine that The New York Times …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times